Vivo Capital’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.94M Hold
2,234,566
0.91% 22
2025
Q1
$7.11M Hold
2,234,566
0.94% 23
2024
Q4
$12M Buy
2,234,566
+737,298
+49% +$3.94M 1.34% 17
2024
Q3
$7.91M Buy
+1,497,268
New +$7.91M 0.65% 25